⌘K

Eledon Pharmaceuticals, Inc. (ELDN)

$2.51 0.45% $0.01 Healthcare

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Market cap

$99.58M

CEO

Dr. David-Alexandre C. Gros M.D., Ph.D.

Full time employees

12.00

Headquarters

Irvine, CA

IPO Date

Sep 17, 2014

Price-to-earnings (PE) Ratio

5.58

Earnings-per-share (EPS)

$0.45

Cash ratio (TTM)

4.32

Current ratio (TTM)

14.48

Net profit margin (TTM)

-13,424.46%

PE ratio (TTM)

-1.42

PEG ratio (TTM)

0.02

Price-to-book ratio (TTM)

-12.53

Price-to-sales ratio (TTM)

178.45

Quick ratio (TTM)

14.48

Return on assets (TTM)

-62.40%

Return on equity (TTM)

-124.74%

Similar stocks (7)

Day One Biopharmaceuticals, Inc.

DAWN

$14.16 2.68% $0.37

Downtrend

Terns Pharmaceuticals, Inc.

TERN

$10.32 1.08% $0.11

Uptrend

Inozyme Pharma, Inc.

INZY

$5.92 1.89% $0.11

Uptrend

Amylyx Pharmaceuticals, Inc.

AMLX

$2.94 2.26% $0.06

Downtrend

HOOKIPA Pharma Inc.

HOOK

$4.65 0.65% $0.03

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.59 6.15% $0.15

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.72 1.75% $0.01

Downtrend

ETF Exposure (10)

iShares Micro-Cap ETF

IWC

0.01401%

$126.54 2.19% $2.71

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

3.0415e-4%

$55.85 1.90% $1.04

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

1.5155e-4%

$34.16 1.86% $0.62

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.50 1.86% $5.16

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$183.01 2.05% $3.67

Uptrend

Neutral

Similar stocks (7)

Day One Biopharmaceuticals, Inc.

DAWN

$14.16 2.68% $0.37

Downtrend

Terns Pharmaceuticals, Inc.

TERN

$10.32 1.08% $0.11

Uptrend

Inozyme Pharma, Inc.

INZY

$5.92 1.89% $0.11

Uptrend

Amylyx Pharmaceuticals, Inc.

AMLX

$2.94 2.26% $0.06

Downtrend

HOOKIPA Pharma Inc.

HOOK

$4.65 0.65% $0.03

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.59 6.15% $0.15

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.72 1.75% $0.01

Downtrend

ETF Exposure (10)

iShares Micro-Cap ETF

IWC

0.01401%

$126.54 2.19% $2.71

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

3.0415e-4%

$55.85 1.90% $1.04

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

1.5155e-4%

$34.16 1.86% $0.62

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.50 1.86% $5.16

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$183.01 2.05% $3.67

Uptrend